论文部分内容阅读
UTILIN“S”(乌体林斯;草分枝杆菌F.U.36)是一种强力免疫刺激剂,自19世纪20年代以来,一直在欧洲用于治疗结核病。2000年,UTILIN“S”被中华医学会结核病分会、北京市结核病胸部肿瘤研究所推荐为结核病免疫治疗首选药。为探讨UTILIN“S”对MDR-TB(耐多药结核病)的免疫增加作用,
UTILIN “S” is a potent immunostimulant that has been used in Europe for the treatment of tuberculosis since the 1820s. In 2000, UTILIN “S” was recommended by the TB Branch of the Chinese Medical Association and the Beijing Tuberculosis and Thoracic Cancer Institute as the preferred drug for immunotherapy of tuberculosis. To investigate the immune-enhancing effect of UTILIN “S” on MDR-TB (multidrug-resistant tuberculosis)